Efficacy and safety of irinotecan combined with raltitrexed or irinotecan monotherapy for salvage chemotherapy of esophageal squamous cell cancer: A prospective, open label, randomized phase II study

Background: Esophageal squamous cell cancer (ESCC) accounts for approximately 90% of esophageal cancer cases in China. There are no standard regimens for second or third–line chemotherapy of metastatic squamous esophageal cancer. The objective of this study was to investigate the security and effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xichao, Tao, Leilei, Wang, Jinqiu, Wu, Wenjuan, Bian, Weigang, Dai, Xichun, Chen, Surong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469638/
https://www.ncbi.nlm.nih.gov/pubmed/37325938
http://dx.doi.org/10.1002/cam4.6264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469638/
https://www.ncbi.nlm.nih.gov/pubmed/37325938
http://dx.doi.org/10.1002/cam4.6264

Ejemplares similares